[Answered] Anthropologists see families as __________. a. kinship systems b. familial networks c. legal ...

This topic contains a solution. Click here to go to the answer

Author Question: Anthropologists see families as __________. a. kinship systems b. familial networks c. legal ... (Read 137 times)

mckennatimberlake

Hero Member
Posts: 559

on: Jul 2, 2018

Anthropologists see families as __________.

a. kinship systems
b. familial networks
c. legal entities
d. inheritance clusters

Question 2

Which of the following groups used violent means to secure rights and privileges?

a. revolutionary colonists
b. native Americans
c. exploited farmers
d. all of the above

Need homework help now?

Ask unlimited questions for free

Ask a Question

Marked as best answer by a Subject Expert

yasmin

Sr. Member
Posts: 319

Reply #1 on: Jul 2, 2018

Answer to Question 1

a

Answer to Question 2

d

mckennatimberlake

Member
Posts: 559

Reply 2 on: Jul 2, 2018

Gracias!

parker125

Member
Posts: 332

Reply 3 on: Yesterday

Excellent

« previous next »

Did you know?

Amoebae are the simplest type of protozoans, and are characterized by a feeding and dividing trophozoite stage that moves by temporary extensions called pseudopodia or false feet.

Did you know?

Vital signs (blood pressure, temperature, pulse rate, respiration rate) should be taken before any drug administration. Patients should be informed not to use tobacco or caffeine at least 30 minutes before their appointment.

Did you know?

Ether was used widely for surgeries but became less popular because of its flammability and its tendency to cause vomiting. In England, it was quickly replaced by chloroform, but this agent caused many deaths and lost popularity.

Did you know?

More than one-third of adult Americans are obese. Diseases that kill the largest number of people annually, such as heart disease, cancer, diabetes, stroke, and hypertension, can be attributed to diet.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.